Study: Daily aspirin may guard against melanoma

06/29/2011 | MSNBC

People who took an aspirin daily for at least five years were almost 50% less likely to get melanoma than people who did not take aspirin, a review of medical records found. "Our data at least support the hypothesis that long-term steady aspirin use has an effect," said Harvard professor of dermatology and study co-author Dr. Robert Stern. The data on other nonsteroidal anti-inflammatory drugs, such as ibuprofen and naproxen, were not as strong, and the researchers found no link between cholesterol-lowering statins and reduced melanoma risk.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY